---
input_text: 'Chelating principles in Menkes and Wilson diseases: Choosing the right
  compounds in the right combinations at the right time.Dysregulation of copper homeostasis
  in humans is primarily found in two genetic diseases of copper transport, Menkes
  and Wilson diseases, which show symptoms of copper deficiency or overload, respectively.
  However, both diseases are copper storage disorders despite completely opposite
  clinical pictures. Clinically, Menkes disease is characterized by copper deficiency
  secondary to poor loading of copper-requiring enzymes although sufficient body copper.
  Copper accumulates in non-hepatic tissues, but is deficient in blood, liver, and
  brain. In contrast, Wilson disease is characterized by symptoms of copper toxicity
  secondary to accumulation of copper in several organs most notably brain and liver,
  and a saturated blood copper pool. It is a challenge to correct copper dyshomeostasis
  in either disease though copper depletion in Menkes disease is most challenging.
  Both diseases are caused by defective copper export from distinct cells, and we
  seek to give new angles and guidelines to improve treatment of these two complementary
  diseases. Therapy of Menkes disease with copper-histidine, thiocarbamate, nitrilotriacetate
  or lipoic acid is discussed. In Wilson disease combination of a hydrophilic chelator
  e.g. trientine or dimercaptosuccinate with a brain shuttle e.g. thiomolybdate or
  lipoate, is discussed. New chelating principles for copper removal or delivery are
  outlined.'
raw_completion_output: |-
  primary_disease: Menkes and Wilson diseases

  medical_actions: Therapy with copper-histidine; Therapy with thiocarbamate; Therapy with nitrilotriacetate; Therapy with lipoic acid; Combination therapy with trientine; Combination therapy with dimercaptosuccinate; Use of brain shuttle thiomolybdate; Use of brain shuttle lipoate; New chelating principles for copper removal; New chelating principles for copper delivery

  symptoms: Copper deficiency; Copper overload; Copper accumulates in non-hepatic tissues; Copper is deficient in blood, liver, and brain; Symptoms of copper toxicity; Accumulation of copper in several organs notably brain and liver; Saturated blood copper pool

  chemicals: Copper-histidine; Thiocarbamate; Nitrilotriacetate; Lipoic acid; Trientine; Dimercaptosuccinate; Thiomolybdate; Lipoate

  action_annotation_relationships: Therapy with copper-histidine TREATS copper deficiency IN Menkes disease; Therapy with thiocarbamate TREATS copper deficiency IN Menkes disease; Therapy with nitrilotriacetate TREATS copper deficiency IN Menkes disease; Therapy with lipoic acid TREATS copper deficiency IN Menkes disease; Combination therapy with trientine (with dimercaptosuccinate) TREATS symptoms of copper toxicity IN Wilson disease; Use of brain shuttle thiomolybdate TREATS symptoms of copper toxicity IN Wilson disease; Use of brain shuttle lipoate TREATS symptoms of copper toxicity IN Wilson disease; New chelating principles for copper removal or delivery TREATS copper overload IN Menkes and Wilson diseases
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  New chelating principles for copper removal or delivery TREATS copper overload IN Menkes and Wilson diseases

  ===

extracted_object:
  primary_disease: Menkes and Wilson diseases
  medical_actions:
    - Therapy with copper-histidine
    - Therapy with thiocarbamate
    - Therapy with nitrilotriacetate
    - Therapy with lipoic acid
    - Combination therapy with trientine
    - Combination therapy with dimercaptosuccinate
    - Use of brain shuttle thiomolybdate
    - Use of brain shuttle lipoate
    - New chelating principles for copper removal
    - New chelating principles for copper delivery
  symptoms:
    - HP:0011967
    - Copper overload
    - Copper accumulates in non-hepatic tissues
    - Copper is deficient in blood, liver, and brain
    - Symptoms of copper toxicity
    - Accumulation of copper in several organs notably brain and liver
    - Saturated blood copper pool
  chemicals:
    - Copper-histidine
    - CHEBI:38127
    - CHEBI:25548
    - CHEBI:16494
    - CHEBI:39501
    - Dimercaptosuccinate
    - CHEBI:30703
    - CHEBI:30313
  action_annotation_relationships:
    - subject: MAXO:0001298
      predicate: TREATS
      object: HP:0011967
      qualifier: MONDO:0010651
      subject_extension: copper-histidine
    - subject: MAXO:0001298
      predicate: TREATS
      object: HP:0011967
      qualifier: MONDO:0010651
      subject_extension: CHEBI:38127
    - subject: MAXO:0001298
      predicate: TREATS
      object: HP:0011967
      qualifier: MONDO:0010651
      subject_extension: CHEBI:25548
    - subject: MAXO:0001298
      predicate: TREATS
      object: HP:0011967
      qualifier: MONDO:0010651
      subject_extension: CHEBI:16494
    - subject: Combination therapy
      predicate: TREATS
      object: symptoms of copper toxicity
      qualifier: MONDO:0010200
      subject_extension: CHEBI:39501
      object_extension: with dimercaptosuccinate
    - subject: Use of brain shuttle
      predicate: TREATS
      object: symptoms
      qualifier: MONDO:0010200
      subject_extension: CHEBI:30703
      object_extension: copper toxicity
    - subject: Use of brain shuttle
      predicate: TREATS
      object: symptoms of copper toxicity
      qualifier: MONDO:0010200
      subject_extension: CHEBI:30313
    - subject: <copper removal or delivery>
      predicate: <TREATS>
      object: <copper overload>
      qualifier: <Menkes and Wilson diseases>
      subject_qualifier: <New>
      object_qualifier: <NA>
      subject_extension: <chelating principles>
      object_extension: <copper overload>
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001663
    label: ventricular fibrillation
  - id: CHEBI:38161
    label: Chelating agents
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0001392
    label: Hepatic disease
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: CHEBI:28694
    label: Copper (Cu)
  - id: CHEBI:18248
    label: Iron (Fe)
  - id: CHEBI:27363
    label: Zinc (Zn)
  - id: CHEBI:82594
    label: Ferritin (SFr)
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0001541
    label: Ascites
  - id: HP:0001394
    label: Cirrhosis
  - id: CHEBI:46195
    label: Paracetamol
  - id: HP:0006554
    label: Acute Liver Failure
  - id: CHEBI:21547
    label: N-acetyl aspartate (NAA)
  - id: CHEBI:15354
    label: Choline (Cho)
  - id: CHEBI:157802
    label: Creatine (Cr)
  - id: MAXO:0009095
    label: Treatment with zinc
  - id: HP:0001399
    label: Liver failure
  - id: CHEBI:7959
    label: d-penicillamine
  - id: CHEBI:39501
    label: Trientine
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0033771
    label: pleuritic chest pain
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: MAXO:0035080
    label: apoptosis assays
  - id: CHEBI:33709
    label: amino acids
  - id: MONDO:0013792
    label: Intracerebral Hemorrhage
  - id: HP:0001342
    label: Intracerebral hemorrhage
  - id: MONDO:0014789
    label: CCDC115-CDG
  - id: HP:0003124
    label: hypercholesterolemia
  - id: HP:0003155
    label: elevated alkaline phosphatases
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: MAXO:0001181
    label: Serum alkaline phosphatase measurement
  - id: HP:0032199
    label: Abnormal prothrombin time
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: CHEBI:50868
    label: Penicillamine
  - id: HP:0001878
    label: hemolytic anemia
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0005135
    label: T wave abnormality
  - id: HP:0011703
    label: sinus tachycardia
  - id: HP:0001688
    label: sinus bradycardia
  - id: HP:0006682
    label: premature ventricular contraction
  - id: CHEBI:35623
    label: antiepileptics
  - id: HP:0001410
    label: Hepatic dysfunction
  - id: CHEBI:62984
    label: Zinc acetate
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (AML)
  - id: HP:0001873
    label: Thrombocytopenia
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0004808
    label: Acute Myeloid Leukemia
  - id: HP:0001336
    label: Myoclonus
  - id: HP:0001250
    label: Epileptic seizures
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0001337
    label: Tremor
  - id: HP:0002315
    label: Headache
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: HP:0001882
    label: leukopenia
  - id: MONDO:0007329
    label: Indian childhood cirrhosis
  - id: HP:0001945
    label: fever
  - id: HP:0002908
    label: direct hyperbilirubinemia
  - id: HP:0002910
    label: elevated transaminases
  - id: HP:0001903
    label: anemia
  - id: HP:0001409
    label: portal hypertension
  - id: MONDO:0004789
    label: Cholangitis
  - id: MAXO:0000127
    label: Genetic analysis
  - id: MONDO:0007256
    label: Hepatocellular carcinoma (HCC)
  - id: CHEBI:26708
    label: NA
  - id: HP:0001402
    label: Hepatocellular carcinoma (HCC)
  - id: MAXO:0001298
    label: therapy
  - id: MONDO:0019542
    label: Acute Liver Failure
  - id: HP:0002359
    label: Frequent Falls
  - id: MONDO:0015143
    label: Rare movement disorders
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0033329
    label: Abnormal postural reflex
  - id: MONDO:0002492
    label: acute kidney injury
  - id: MAXO:0000973
    label: slit-lamp examination
  - id: HP:0033429
    label: Neuroinflammation
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:28938
    label: ammonia
  - id: HP:0001433
    label: hepatosplenomegaly
  - id: HP:0002904
    label: hyperbilirubinemia
  - id: HP:0003256
    label: coagulopathy
  - id: MONDO:0012105
    label: ANCA-associated Vasculitis
  - id: HP:0002105
    label: Hemoptysis
  - id: HP:0002094
    label: Dyspnea
  - id: HP:0002907
    label: Microscopic hematuria
  - id: HP:0000093
    label: Proteinuria
  - id: CHEBI:24261
    label: Glucocorticoid
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: HP:0040223
    label: pulmonary hemorrhage
  - id: HP:0000790
    label: hematuria
  - id: MONDO:0100193
    label: End-stage liver diseases
  - id: HP:0002040
    label: Esophageal varices
  - id: HP:0100626
    label: End-stage liver diseases
  - id: MONDO:0017014
    label: children
  - id: HP:0200123
    label: chronic hepatitis
  - id: HP:0001397
    label: steatosis
  - id: CHEBI:28787
    label: targeted next-generation sequencing (NGS)
  - id: MAXO:0000527
    label: Physical examination
  - id: MAXO:0010200
    label: Abdominal ultrasonography (Abdl Ur)
  - id: HP:0010837
    label: Decreased serum ceruloplasmin
  - id: CHEBI:37708
    label: Alanine transaminase (ALT)
  - id: CHEBI:76649
    label: Aspartate transaminase (AST)
  - id: HP:0200120
    label: chronic active hepatitis
  - id: HP:0002896
    label: liver cancer
  - id: HP:0002354
    label: memory dysfunction
  - id: HP:0100543
    label: cognitive impairment
  - id: CHEBI:23414
    label: CuSO4
  - id: CHEBI:16856
    label: glutathione (GSH)
  - id: CHEBI:566274
    label: malondialdehyde (MDA)
  - id: CHEBI:31882
    label: N-methyl-D-aspartate
  - id: HP:0002885
    label: Mallory-Denk body (MDB) formation
  - id: CHEBI:16990
    label: Bilirubin
  - id: HP:0001266
    label: choreoathetosis
  - id: MAXO:0009101
    label: early intervention
  - id: HP:0012594
    label: microalbuminuria
  - id: HP:0002150
    label: hypercalciuria
  - id: CHEBI:888
    label: Sodium dimercaptopropanesulfonate (DMPS)
  - id: CHEBI:35176
    label: zinc sulfate
  - id: MAXO:0000137
    label: PET scans
  - id: CHEBI:17234
    label: Glucose
  - id: MONDO:0005556
    label: Lupus Nephritis
  - id: MAXO:0000165
    label: Treatment with diuretics
  - id: CHEBI:35498
    label: Diuretics
  - id: CHEBI:33281
    label: Antibiotics
  - id: CHEBI:50503
    label: Laxatives
  - id: CHEBI:74067
    label: Copper(II)
  - id: CHEBI:6801
    label: 2-N, N-dimethylcarbamimidoyl (metformin)
  - id: HP:0004787
    label: Fulminant hepatitis
  - id: MAXO:0010026
    label: Zinc supplementation
  - id: HP:0011967
    label: Copper deficiency
  - id: CHEBI:38127
    label: Thiocarbamate
  - id: CHEBI:25548
    label: Nitrilotriacetate
  - id: CHEBI:16494
    label: Lipoic acid
  - id: CHEBI:30313
    label: Lipoate
  - id: MONDO:0010651
    label: Menkes disease
